Evidence map›Paper›PMID 41126901›Full record

ReviewJournal of the Pediatric Orthopaedic Society of North America2025

The Natural History of Scheuermann's Kyphosis.

David M Bennett

Abstract readReview
In one paragraph

Review in Journal of the Pediatric Orthopaedic Society of North America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David M BennettPhoenix Children's Hospital, Phoenix, AZ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adolescent idiopathic kyphosis, also known as Scheuermann's kyphosis (SK), is a prominent form of thoracic or thoracolumbar spine hyperkyphosis affecting up to 8% of adolescents. This condition is characterized by structural vertebral changes and a kyphotic Cobb angle greater than 45°. This review examines the long-term progression and outcomes of SK when untreated, integrating findings from multiple decades of research, including landmark studies. By engaging with this review, we hope to convey a consolidated understanding of how Scheuermann's kyphosis behaves across the lifespan when untreated; from the modest rate of post-maturity progression to the clinical signals that separate stable curves from those likely to cause functional difficulty. The information can provide clarity when advising families, planning follow-up, and determining when continued non-operative care is reasonable or when surgical intervention might be considered. Key Concepts: (1)Scheuermann's kyphosis affects roughly eight percent of adolescents and is defined by structural vertebral wedging that produces a thoracic Cobb angle greater than 45°.(2)Longitudinal cohorts show that after skeletal maturity, the curve enlarges only about a third to half a degree each year, with very few patients ever exceeding 100°.(3)Pain and everyday function are usually acceptable, yet individuals whose curves pass 75° and develop forward sagittal imbalance report noticeably greater disability.(4)Radiographic size alone does not predict symptoms; the combination of deformity and loss of global alignment is a more reliable signal for clinical vigilance.(5)Conservative measures such as physiotherapy and bracing during growth suffice for most patients, while operative consultation is reserved for those with progressive imbalance or persistent discomfort.

Indexed as

Adolescent kyphosisLong-term prognosisNon-surgical treatmentScheuermann's kyphosisSpinal health

Identifiers

PMID41126901
PMCPMC12538408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.